Vietnam’s Imexpharm Loans Millions For COVID-19 Response
Financing Agreement With ABD Will Ensure Supply
Vietnamese firm Imexpharm has received $8m in financing from the Asian Development Bank to help sustain local production considering the novel coronavirus pandemic.
You may also be interested in...
Novartis has expanded its efforts to help low- and lower-middle-income countries “mitigate the impact of the pandemic and support healthcare systems,” after signing a memorandum of understanding with Vietnam’s Ministry of Health providing various treatments for COVID-19 at-cost.
As biosimilars to Stelara (ustekinumab) continue to advance in global markets, Rani Therapeutics has made progress for its proposed RT-111 orally administered ustekinumab biosimilar.
Following the formation of their partnership nearly five years ago, Alvotech and Fuji have together welcomed approval in Japan for Alvotech’s biosimilar to Stelara (ustekinumab).